MX2010001866A - Derivados de azoloarina, metodo para su produccion, productos farmaceuticos que contienen estos compuestos y su uso. - Google Patents

Derivados de azoloarina, metodo para su produccion, productos farmaceuticos que contienen estos compuestos y su uso.

Info

Publication number
MX2010001866A
MX2010001866A MX2010001866A MX2010001866A MX2010001866A MX 2010001866 A MX2010001866 A MX 2010001866A MX 2010001866 A MX2010001866 A MX 2010001866A MX 2010001866 A MX2010001866 A MX 2010001866A MX 2010001866 A MX2010001866 A MX 2010001866A
Authority
MX
Mexico
Prior art keywords
compounds
azoloraine
derivatives
production
pharmaceuticals containing
Prior art date
Application number
MX2010001866A
Other languages
English (en)
Inventor
Andreas Herling
Gerhard Zoller
Christophe Philippo
Hans Matter
Marc Dietrich Voss
Claudie Namane
Juan-Antonio Sanchez-Arias
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of MX2010001866A publication Critical patent/MX2010001866A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

La invención se refiere a compuestos de la fórmula I (ver fórmula I) en donde los radicales R, M, W, X, A, B, D e Y tienen los significados indicados, y sus sales fisiológicamente toleradas. Los compuestos son adecuados, por ejemplo, para el tratamiento del síndrome metabólico, la resistencia a la insulina, la obesidad y la diabetes.
MX2010001866A 2007-08-23 2008-08-14 Derivados de azoloarina, metodo para su produccion, productos farmaceuticos que contienen estos compuestos y su uso. MX2010001866A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07291036 2007-08-23
EP08290181 2008-02-25
PCT/EP2008/006685 WO2009024287A2 (de) 2007-08-23 2008-08-14 Azoloarin derivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung

Publications (1)

Publication Number Publication Date
MX2010001866A true MX2010001866A (es) 2010-03-11

Family

ID=40317033

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010001866A MX2010001866A (es) 2007-08-23 2008-08-14 Derivados de azoloarina, metodo para su produccion, productos farmaceuticos que contienen estos compuestos y su uso.

Country Status (11)

Country Link
US (1) US20100240580A1 (es)
EP (1) EP2183222B1 (es)
JP (1) JP2010536811A (es)
KR (1) KR20100052482A (es)
CN (1) CN101784528A (es)
AT (1) ATE518839T1 (es)
AU (1) AU2008290864A1 (es)
BR (1) BRPI0815731A2 (es)
CA (1) CA2696693A1 (es)
MX (1) MX2010001866A (es)
WO (1) WO2009024287A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012020725A1 (ja) * 2010-08-10 2012-02-16 塩野義製薬株式会社 Ｎｐｙ ｙ５受容体拮抗作用を有するヘテロ環誘導体
US20130197043A1 (en) 2010-08-31 2013-08-01 Snu R&Db Foundation Use of the fetal reprogramming of a ppar agonist
CN104059039B (zh) * 2013-03-22 2017-03-15 正大天晴药业集团股份有限公司 具有gpr40受体功能调节作用的稠环化合物
EP3263109B1 (en) 2015-02-24 2020-06-17 National University Corporation Tottori University Drug for preventing and/or treating dementia
CN108727295B (zh) * 2018-06-21 2022-04-01 济南大学 一种2-(3-氨基苯基)-苯并噻唑衍生物及其制备方法和用途
US20230227412A1 (en) * 2020-07-10 2023-07-20 Chengdu Fanxi Biopharma Co., Ltd. Substituted Benzimidazole Derivative And Use Thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5942532A (en) * 1997-09-05 1999-08-24 Ortho Pharmaceutical Corporation 2-substituted phenyl-benzimidazole antibacterial agents
EP1763350B1 (en) * 2004-07-06 2011-12-21 Xenon Pharmaceuticals Inc. Nicotinamide derivatives and their use as therapeutic agents
ATE369854T1 (de) * 2001-10-19 2007-09-15 Ortho Mcneil Pharm Inc 2-phenyl benzimidazole und imidazo-[4,5]-pyridine als cds1/chk2-inhibitoren und adjuvantien in der chemotherapie oder strahlungstherapie zur behandlung von krebs
US7696210B2 (en) * 2004-06-17 2010-04-13 Wyeth Gonadotropin releasing hormone receptor antagonists
AU2006315025A1 (en) * 2005-11-15 2007-05-24 Merck Frosst Canada Ltd. Azacyclohexane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase

Also Published As

Publication number Publication date
EP2183222A2 (de) 2010-05-12
WO2009024287A2 (de) 2009-02-26
KR20100052482A (ko) 2010-05-19
CN101784528A (zh) 2010-07-21
US20100240580A1 (en) 2010-09-23
CA2696693A1 (en) 2009-02-26
EP2183222B1 (de) 2011-08-03
ATE518839T1 (de) 2011-08-15
WO2009024287A3 (de) 2009-05-07
BRPI0815731A2 (pt) 2015-02-18
AU2008290864A1 (en) 2009-02-26
JP2010536811A (ja) 2010-12-02

Similar Documents

Publication Publication Date Title
MY149648A (en) Carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament
MX2009007180A (es) Agonistas del receptor acoplado a la proteina g de la piperidina.
MX2009012285A (es) Inhibidores de diacilglicerol aciltransferasa.
WO2010003624A3 (en) Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
MY149622A (en) Pyrazoles as 11-beta-hsd-1
HK1158192A1 (en) Piperidine gpcr agonists
MX2009011112A (es) Derivados de 2-heteroaril-pirrolo[3,4-cipirrolo y su uso como inhibidores de scd.
WO2009010416A3 (en) Inhibitors of 11b-hydroxysteroid dehydrogenase
DE602006009095D1 (en) Diacylglycerol-acyltransferase-hemmer
HK1135703A1 (en) Piperidine gpcr agonists
GB0812642D0 (en) Compounds
WO2009100936A3 (de) Neue aromatische fluorglykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2007060140A3 (en) Inhibitors of diacyglycerol acyltransferase (dgat)
UA97257C2 (en) Indole derivatives
MY148483A (en) 4,5-diphenyl-pyrimidinyl-oxy or-mercapto substituted carboxylic acids, method for the production and use thereof as medicaments
WO2006112549A8 (ja) 縮合複素環化合物
MX2011005934A (es) Compuestos organicos.
WO2007082808A3 (en) Thiazoles as 11 beta-hsd1 inhibitors
TN2012000248A1 (en) Novel spiropiperidine compounds
NO20085067L (no) 4,5-difenyl-pyrimidinyl substituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
WO2008001195A3 (en) Novel processes for the preparation of dpp iv inhibitors
MX2010001866A (es) Derivados de azoloarina, metodo para su produccion, productos farmaceuticos que contienen estos compuestos y su uso.
WO2010052144A3 (en) Neuropeptide-2-receptor (y-2r) agonists and uses thereof
WO2011045232A3 (en) Neuropeptide-2 receptor (y-2r) agonists
MY152475A (en) Fused ring compounds and use thereof

Legal Events

Date Code Title Description
FA Abandonment or withdrawal